Sustained Efficacy and Seroconversion with the Toll-Like Receptor 7 Agonist GS-9620 in the Woodchuck Model of Chronic Hepatitis B

BACKGROUND & AIMS: New therapies for chronic hepatitis B (CHB) are urgently needed since current treatments rarely lead to cure. We evaluated whether the oral small molecule toll-like receptor (TLR7) agonist GS-9620 could induce durable anti-viral efficacy in woodchucks chronically infected with...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Hepatol
Autors principals: Menne, Stephan, Tumas, Daniel B., Liu, Katherine H., Thampi, Linta, AlDeghaither, Dalal, Baldwin, Betty H., Bellezza, Christine A., Cote, Paul J., Zheng, Jim, Halcomb, Randall, Fosdick, Abigail, Fletcher, Simon P., Daffis, Stephane, Li, Li, Yue, Peng, Wolfgang, Grushenka H. I., Tennant, Bud C.
Format: Artigo
Idioma:Inglês
Publicat: 2015
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4439359/
https://ncbi.nlm.nih.gov/pubmed/25559326
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jhep.2014.12.026
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars